Eupraxia Pharmaceuticals establishes at-the-market offering program
EPRX•Eupraxia Pharmaceuticals established an at-the-market program allowing it to offer up to $125 million of common shares.
1. Offering program
The program allows Eupraxia Pharmaceuticals to offer up to $125 million of common shares.
